| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-02 | FY 2024
FILED 2025-01-03 | FY 2023
FILED 2023-12-29 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $21.32B | $19.42B |
| YoY Revenue Growth % | — | +9.8% | — |
| Gross Profit | $0 | $5.52B | — |
| Gross Margin % | — | 25.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.11B | $1.92B | $1.43B |
| Operating Margin % | — | 9.0% | 7.3% |
| Net Income (GAAP) | $1.61B | $1.50B | $1.23B |
| EBITDA (Normalized) | $2.45B | $2.24B | $2.13B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.11B | $2.56B | $2.10B |
| Capital Expenditures (CapEx) | $424.0M | $408.0M | $873.9M |
| Free Cash Flow (FCF) | $2.68B | $2.15B | $1.22B |
| FCF Margin % | — | 10.1% | 6.3% |
| Return on Invested Capital (ROIC %) | 5.7% | 5.1% | 6.5% |
| Cash & Short-Term Equivalents | $1.07B | $615.0M | — |
| Total Debt (Short + Long Term) | $10.44B | $11.08B | $6.67B |
| Total Stockholders' Equity | $19.64B | $19.51B | $13.69B |